David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$397M |
| 2 |
YHOO
Yahoo Inc
YHOO
|
+$342M |
| 3 |
Bank of America
BAC
|
+$322M |
| 4 |
Citigroup
C
|
+$260M |
| 5 |
Booking.com
BKNG
|
+$219M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$637M |
| 2 |
BRCM
BROADCOM CORP CL-A
BRCM
|
+$397M |
| 3 |
Gilead Sciences
GILD
|
+$358M |
| 4 |
Phillips 66
PSX
|
+$330M |
| 5 |
Apple
AAPL
|
+$320M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.78% |
| 2 | Technology | 11.11% |
| 3 | Financials | 10% |
| 4 | Consumer Discretionary | 8.83% |
| 5 | Communication Services | 8.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FNFG
2426
DELISTED
FIRST NIAGARA FINANCIAL GROUP INC
FNFG
| $864K | ﹤0.01% |
89,261
+54,168
| +154% | +$524K |
|
|
HGG
2427
DELISTED
hhgregg Inc.
HGG
| $861K | ﹤0.01% |
408,143
-13,409
| -3% | -$27.7K |
|
2428
Rayonier Advanced Materials
RYAM
$582M
| $860K | ﹤0.01% |
90,528
-457,338
| -83% | -$3.61M |
|
2429
CALL
Dollar General
DG
$27B
| $856K | ﹤0.01% |
10,000
-15,400
| -61% | -$1.17M |
|
2430
AMERISAFE
AMSF
$485M
| $855K | ﹤0.01% |
16,266
+11,220
| +222% | +$565K |
|
|
KSU
2431
CALL
DELISTED
Kansas City Southern
KSU
| $855K | ﹤0.01% |
10,000
-12,600
| -56% | -$983K |
|
|
IDTI
2432
DELISTED
Integrated Device Technology I
IDTI
| $855K | ﹤0.01% |
41,813
-517,744
| -93% | -$10.9M |
|
|
FLXN
2433
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $854K | ﹤0.01% |
92,815
+66,060
| +247% | +$801K |
|
|
SCMP
2434
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
| $854K | ﹤0.01% |
78,091
+60,870
| +353% | +$769K |
|
2435
ORIX
IX
$42.9B
| $853K | ﹤0.01% |
59,720
+8,000
| +15% | +$109K |
|
2436
CALL
UnitedHealth
UNH
$356B
| $851K | ﹤0.01% |
6,600
-30,200
| -82% | -$3.57M |
|
|
MPSX
2437
DELISTED
Multi Packaging Solutions Intl.
MPSX
| $851K | ﹤0.01% |
52,403
-15,239
| -23% | -$240K |
|
2438
NVR
NVR
$17.1B
| $849K | ﹤0.01% |
490
-6,121
| -93% | -$9.9M |
|
|
TWX
2439
PUT
DELISTED
Time Warner Inc
TWX
| $849K | ﹤0.01% |
11,700
-107,900
| -90% | -$7.43M |
|
2440
Pan American Silver
PAAS
$22.5B
| $848K | ﹤0.01% |
77,979
-2,800
| -3% | -$24K |
|
2441
CALL
Rio Tinto
RIO
$174B
| $848K | ﹤0.01% |
+30,000
| New | +$799K |
|
2442
Koppers
KOP
$872M
| $846K | ﹤0.01% |
37,658
-54,655
| -59% | -$974K |
|
2443
UNIFI
UFI
$139M
| $846K | ﹤0.01% |
+36,938
| New | +$877K |
|
2444
DexCom
DXCM
$33.6B
| $845K | ﹤0.01% |
+49,796
| New | +$832K |
|
|
ITG
2445
DELISTED
Investment Technology Group Inc
ITG
| $845K | ﹤0.01% |
38,239
-69,105
| -64% | -$1.27M |
|
|
FDC
2446
DELISTED
First Data Corporation
FDC
| $844K | ﹤0.01% |
+65,250
| New | +$839K |
|
2447
Casella Waste Systems
CWST
$5.95B
| $841K | ﹤0.01% |
125,539
+12,843
| +11% | +$77.4K |
|
2448
Immersion
IMMR
$254M
| $840K | ﹤0.01% |
101,684
-5,731
| -5% | -$47.4K |
|
2449
PUT
Regal Rexnord
RRX
$10.8B
| $839K | ﹤0.01% |
+13,300
| New | +$745K |
|
|
OB
2450
DELISTED
Onebeacon Insurance Group Ltd
OB
| $838K | ﹤0.01% |
65,823
+12,089
| +22% | +$154K |
|
Similar funds
David Shaw's Q1 2016 Portfolio in Review
As of Q1 2016, David Shaw held 4,137 positions worth $55.7B, down 17% from $67.2B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.
David Shaw withdrew a net $9.72B in Q1 2016, closing 773 positions and reducing 1,495 holdings. Its most notable exit was PRECISION CASTPARTS CORP, an estimated $637M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 13% a quarter earlier, followed by Technology and Financials.
Against the trend, David Shaw opened a new position in EQT Corp worth $47.6M.
- David Shaw's largest Q1 2016 buy was EQT Corp: 1,300,361 shares worth $47.6M.
- David Shaw added most to Allergan plc in Q1 2016, an estimated $397M increase.
- David Shaw's biggest Q1 2016 reduction was Gilead Sciences, cutting an estimated $358M.
- David Shaw fully exited PRECISION CASTPARTS CORP in Q1 2016, selling an estimated $637M.
- David Shaw's ten largest holdings make up 9.5% of its $55.7B portfolio in Q1 2016.
- David Shaw opened 382 new positions and closed 773 in Q1 2016.
- David Shaw's portfolio value fell 17% quarter-over-quarter to $55.7B.
Based on D.E. Shaw & Co's 13F filing for Q1 2016, filed 16 May 2016.